[Long-term treatment using prostaglandin E2 in congenital heart defects with the pulmonary circulation being supplied by a patent ductus arteriosus].
D015232:Dinoprostone; D004374:Ductus Arteriosus, Patent / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006330:Heart Defects, Congenital / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D007231:Infant, Newborn; D011458:Prostaglandins E / Q000627:therapeutic use*; D011652:Pulmonary Circulation
D011458:Prostaglandins E; D015232:Dinoprostone
Dlouhodobá lécba prostaglandiny E2 u vrozených srdecních vad s plicním recistĕm zásobovaným otevrenou tepennou ducejí.